Subscribe To
Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD
Use of these more-potent P2Y12 inhibitors over clopidogrel has become widely accepted—and guideline supported—in clinical practice for patients following ACS, with ISAR-REACT-5 showing an advantage … Read Full Story at source (may require registration) The post Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD appeared first on ForexTV...
Read More
Posted: Nov 21 2022, 19:36
Author Name: forextv
Views: 110839